当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
オープンアクセスジャーナルはより多くの読者と引用を獲得 700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
短報
Enhanced Temozolomide Resistance in Glioblastoma by the Novel Cancer Stem Cell Marker MVP
解説
Effects of Heated Tobacco Products' Extract from Cigarette Smoke on the Growth of Lung Cancer Stem Cells
専門家のレビュー
Direct Cell-Cell Communication Controls the Division of the PC-3 Human Prostate Cancer Cell Line's Stem Cells
ケーススタディ
A Comparison of the Ability of Three Different Cancer Stem Cell Cultures to Spread
迅速な通信
Results from A Longitudinal Cohort and Mendelian Randomization Study Show A Relationship Between the Age at Diabetes Beginning or the Length of Diabetes and the Risk of Developing Pancreatic Cancer Later
研究論文
Lanthanum, Yttrium Iron Oxide with Nanoparticles Structural, Magnetic Analysis, and Their Anti-Cancer Application
ミニレビュー
A Digital Patient-Input Tool that Combines Family Cancer History Screening and Newly Diagnosed Diabetes can be Used to Identify Those Who are at High Risk for Developing Pancreatic Cancer
Gemcitabine and Triapine Co-Delivery Using Calcium Carbonate Nanoparticles for the Treatment of Chemo-resistant Pancreatic Cancer
A Novel Strategy is Used to Predict the Tumour Microenvironment and Therapy Targets for Pancreatic Cancer by Evaluating Necroptosis and Immunological State
An Analysis Using Propensity Scores Reveals that Monitoring High-Risk Individuals for Pancreatic Cancer Results in Better Outcomes